ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Epidemiology"

  • Abstract Number: 1700 • ACR Convergence 2023

    Incidence and Risk Factors for New Onset of Interstitial Lung Disease in Systemic Sclerosis: A EUSTAR Analysis

    liubov Petelytska1, Arthiha Velauthapillai2, Lorenzo Tofani3, Eric Hachulla4, Ulf Müller-Ladner5, Elise Siegert6, Yannick ALLANORE7, Gabriela Riemekasten8, Christina Bergmann9, Radim Becvar10, Kamal Solanki11, Branimir Anic12, Simona Rednic13, Bojana Stamenkovic14, Lisa Stamp15, Joerg Distler16, Madelon Vonk17, Jeska de Vries-Bouwstra18, Anna Maria Hoffmann-Vold19, marco Matucci Cerinic20, Oliver Distler21 and Cosimo Bruni21, 1Department of Rheumatology, University Hospital Zurich, University of Zurich, Zürich, Switzerland, 2Department of Rheumatology, Radboud University Medical Center, Nijmegen, Netherlands, 3Department of Statistics, Computer Science, Applications, University of Florence, Florence, Italy, 4University of Lille, Lille, France, 5Justus Liebig University Gießen, Campus Kerckhoff, Bad Nauheim, Germany, 6Department of Rheumatology, Charité University Hospital, Charité Platz 1, D-10117, Berlin, Germany, 7Université Paris Cité, Paris, France, 8University Clinic Schleswit-Holstein (UKSH), Lübeck, Germany, 9Department of Internal Medicine 3-Rheumatology and Immunology, Friedrich-Alexander-University Erlangen-Nürnberg (FAU) and University Hospital Erlangen, Erlangen, Germany, 10Institute of Rheumatology, Prague, Czech Republic, Department of Rheumatology, 1st Faculty of Medicine, Charles University, Praha, Czech Republic, 11Department of Rheumatology, Te Whatu Ora Health New Zealand Waikato, Hamilton, New Zealand, 12Division of Clinical Immunology and Rheumatology, Department of Internal Medicine, University of Zagreb, School of Medicine, University Hospital Center Zagreb, Kišpatićeva 12, 10 000, Zagreb, Croatia, 13Prof Dr Simona Rednic, Cluj, Romania, 14Institut Niska Banja, Niska Banja, Serbia, 15University of Otago, Christchurch, New Zealand, 16Clinic for Rheumatology University Hospital Düsseldorf, Medical Faculty of Heinrich Heine University, Düsseldorf, Germany; Hiller Research Center, University Hospital Düsseldorf, Medical Faculty of Heinrich Heine University, Düsseldorf, Germany, 17Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands, 18Leiden University Medical Center, Leiden, Netherlands, 19Oslo University Hospital, Department of Rheumatology, Oslo, Norway, 20Unit of Immunology, Rheumatology, Allergy and Rare diseases, IRCCS San Raffaele Hospital, Milan, Milan, Italy, 21Department of Rheumatology, University Hospital Zurich, University of Zurich, Zurich, Switzerland

    Background/Purpose: Although prevalence of interstitial lung disease (ILD) in systemic sclerosis (SSc) and associated risk factors are established, less is known about its incidence and…
  • Abstract Number: 1915 • ACR Convergence 2023

    Scleritis and Development of Autoimmune Disease: A Case Series

    Tessalyn Morrison1, Moriah Gottman2, Marcia Friedman3 and Daniela Ghetie4, 1University of Vermont, Burlington, VT, 2Oregon Health & Science University, Milwaukie, OR, 3Alpine Immune Sciences, Inc., Beaverton, OR, 4Oregon Health & Science University, Portland, OR

    Background/Purpose: Scleritis involves inflammation of the sclera caused by trauma, infections, or autoimmune conditions. The purpose of our study was to understand the relationship between…
  • Abstract Number: 2222 • ACR Convergence 2023

    Association Spondyloarthritis and Inflammatory Bowel Disease, More Severe Diseases on Both Sides

    Juliane Michel1, Clément Prati2, Lucine Vuitton3, Eric Toussirot4, Charline Vauchy5, Daniel Wendling6 and frank Verhoeven2, 1Rheumatology, CHU Besancon, Besançon, France, 2Service de rhumatologie, CHU de Besançon, Besançon, France, 3Gastroenterology, CHU Besancon, Besançon, France, 4University Hospital of Besancon, Besançon, France, 5INSERM CIC-1431, Besançon, France, 6Besançon University Hospital, Besançon, France

    Background/Purpose: There is a pathophysiological link between spondyloarthritis (SpA) and Inflammatory Bowel Disease (IBD), so that 10% of IBD is estimated to have SpA and…
  • Abstract Number: 2480 • ACR Convergence 2023

    Definition of Rheumatoid Arthritis Flare Based on SDAI and CDAI

    Victoria Konzett1, Andreas Kerschbaumer2, Josef S Smolen3, Eirik Kristianslund4, Sella Provan4, Tore Kvien5 and Daniel Aletaha6, 1Medical University of Vienna, Wien, Austria, 2Medical University of Vienna, Vienna, Austria, 3Division of Rheumatology, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria, 4Diakonhjemmet Hospital, Oslo, Norway, 5Center for Treatment of Rheumatic and Musculoskeletal Diseases (REMEDY), Diakonhjemmet Hospital, Oslo, Norway, 6Division of Rheumatology, Department of Medicine III, Medical University of Vienna, Vienna, Austria, Wien, Austria

    Background/Purpose: Measures of improvement and state of disease activity are well-established in rheumatoid arthritis (RA), whereas distinct classifiers for worsening (“flare”) are lacking to date.…
  • Abstract Number: 098 • 2023 Pediatric Rheumatology Symposium

    Characterization of Pulmonary Nodules in Juvenile-onset Systemic Sclerosis: A Single Center Case-Series

    Jonathan Li1, Franziska Rosser1, Sameh Tadros1 and Kathryn Torok2, 1UPMC Children's Hospital of Pittsburgh, Pittsburgh, PA, 2University of Pittsburgh, Pittsburgh, PA

    Background/Purpose: Given the high prevalence of intestinal lung disease (ILD) in systemic sclerosis (SSc) and the low sensitivity of pulmonary function testing for diagnosing ILD,…
  • Abstract Number: 0381 • ACR Convergence 2022

    Most Disease Outcome Measures but Not ASDAS Are Influenced by Gender in Patients with Axial SpA: Results from ASAS-PerSpA

    Diego Benavent1, Dafne Capelusnik2, Sofia Ramiro3, Anna Molto4, Clementina Lopez-Medina5, Maxime Dougados6 and Victoria Navarro-Compán7, 1La Paz University Hospital, Madrid, Spain, 2Instituto de Rehabilitación Psicofísica (IREP), Buenos Aires, Argentina, 3Leiden University Medical Center, Leiden, Netherlands, 4Rheumatology Department, Hôpital Cochin,Assistance Publique- Hôpitaux de Paris, Paris, France, 5Reina Sofia University Hospital, Rheumatology Department, Jaén, Spain, 6Department of Rheumatology, Hôpital Cochin, Paris, France, Paris, France, 7Department of Rheumatology, La Paz University Hospital, IdiPaz, Madrid, Spain

    Background/Purpose: There is growing evidence revealing that females report worse patient-reported outcomes compared to males in axial spondyloarthritis (axSpA). However, in which precise outcomes there…
  • Abstract Number: 0698 • ACR Convergence 2022

    Cohort Study of Cigarette Smoking and the Risk of Developing Polymyalgia Rheumatica Among Women

    Jae Hee Kang1, Susan Malspeis2, Nicole Yang2 and Karen Costenbader2, 1Brigham and Women's Hospital, Harvard Medical School, Boston, MA, 2Brigham and Women's Hospital, Boston, MA

    Background/Purpose: Polymyalgia rheumatica (PMR) is the most common inflammatory rheumatic disease among older White women, but little is known of its etiology and there are…
  • Abstract Number: 0826 • ACR Convergence 2022

    Treatment Pattern and Changes in Oral Glucocorticoid Dose After Tocilizumab Treatment in Patients with Adult Still’s Disease: An Analysis of a Japanese Claims Database

    Yuko Kaneko1, Hideto Kameda2, Kei Ikeda3, Katsuhisa Yamashita4, Ryoto Ozaki5 and Yoshiya Tanaka6, 1Keio University School of Medicine, Tokyo, Japan, 2Toho University, Tokyo, Japan, 3Chiba University Hospital, Chiba, Japan, 4Chugai Pharmaceutical Co., Ltd., Chuo-ku, Tokyo, Japan, 5Chugai Pharmaceutical Co. Ltd., Tokyo, Japan, 6University of Occupational and Environmental Health, Kitakyusyu Fukuoka, Japan

    Background/Purpose: Adult Still's disease (ASD), including adult-onset Still's disease and carry-over systemic juvenile idiopathic arthritis (sJIA), is treated with glucocorticoids (GC) with or without immunosuppressive…
  • Abstract Number: 1193 • ACR Convergence 2022

    Seasonal Variation of Hospitalizations and In-Hospital Mortality Related to Systemic Lupus Erythematosus Among Adults in the United States: An Analysis of Nationwide Inpatient Sample

    Jiayi Zheng1, Ruoning Ni2, Guangchen Zou3, Qianlan Xi4, Tien-Chan Hsieh3 and Shahrzad Abdollahi5, 1The Wright Center for Graduate Medical Education, Scranton, PA, 2Ascension Saint Agnes Hospital, Iowa City, IA, 3Danbury Hospital, Danbury, CT, 4Memorial Hospital West, Pembroke Pines, FL, 5Division of Rheumatology, Lewis Katz School of Medicine, Temple University Hospital, Philadelphia, PA

    Background/Purpose: While the seasonal variation of systemic lupus erythematosus (SLE) disease activity has been reported, population-based studies are still lacking. Here we investigate the seasonal…
  • Abstract Number: 1388 • ACR Convergence 2022

    Updating and Validating the Rheumatic Disease Comorbidity Index to Incorporate ICD-10 Diagnostic Codes

    Anthony Dolomisiewicz1, Hanifah Ali2, Punyasha Roul3, Yangyuna Yang1, Grant Cannon4, Joshua Baker5, Ted Mikuls6, Kaleb Michaud1 and Bryant England1, 1University of Nebraska Medical Center, Omaha, NE, 2UNMC, Omaha, 3UNMC, Omaha, NE, 4Salt Lake City VA, Salt Lake city, 5University of Pennsylvania and Corporal Michael J. Crescenz VA Medical Center, Philadelphia, 6Division of Rheumatology, University of Nebraska Medical Center, Omaha, NE

    Background/Purpose: The Rheumatic Disease Comorbidity Index (RDCI) was designed to quantify comorbidity burden for risk stratification of health outcomes in patients with rheumatic disease. Developed…
  • Abstract Number: 1637 • ACR Convergence 2022

    Association of Dermatomyositis with Cardiovascular Disease: A Case-Control Study in the All of Us Research Program

    Jill Shah1, Keya Shah2, Daniel Mazori1, Avrom Caplan1, Emily Hejazi1 and Alisa Femia1, 1Ronald O. Perelman Department of Dermatology, New York University Langone Health, New York, NY, 2Department of Medicine, NYU Langone Hospital - Long Island, Mineola, NY

    Background/Purpose: Previous studies on the association of dermatomyositis (DM) with cardiovascular (CV) disease have used combined idiopathic inflammatory myositis cohorts, included only non-United States (US)…
  • Abstract Number: 1781 • ACR Convergence 2022

    Knee Pain Is Highly Associated with Ankle/Foot Pain, Arch Height, and Arch Flexibility: The Johnston County Osteoarthritis Project

    Yvonne Golightly1, Marian Hannan2, Howard Hillstrom3, Rajshree Hillstrom4, Mary Catherine Minnig5 and Amanda Nelson6, 1University of Nebraska Medical Center, Omaha, NE, 2Marcus Institute for Aging Research, Hebrew SeniorLife, Milton, MA, 3Hospital for Special Surgery, New York, NY, 4Biomed Consulting, Inc., Manhattan, NY, 5University of North Carolina, Chapel Hill, NC, 6University of North Carolina at Chapel Hill, Chapel Hill, NC

    Background/Purpose: In knee osteoarthritis (OA), the contribution of the ankle and foot up the kinetic chain to the knee is not well understood. Ankle and…
  • Abstract Number: 2169 • ACR Convergence 2022

    Cardiac Rhythm and Conduction Abnormalities in Systemic Sclerosis-meta-analysis

    Drashti Antala1, Angkawipa Trongtorsak1, Qingqing Meng1, Akshaya Ramachandran1, Aanshi Patel2, Pabitra Adhikari1, Prasun Pudasainee1 and Krutarth Pandya3, 1Ascension Saint Francis hospital, Evanston, IL, 2B.J. Medical College, Ahmedabad, Ahmedabad, India, 3Trumbull Regional Medical Centre, Warren, OH

    Background/Purpose: Systemic sclerosis( SSc) can primarily cause repeated focal ischaemic insults in the myocardium and result in irreversible myocardial fibrosis. Myocardial involvement, when becomes clinically…
  • Abstract Number: 0392 • ACR Convergence 2022

    Performance of Clinical, Laboratory and Imaging Features for the Diagnosis of Axial Spondyloarthritis – A Systematic Literature Review

    Ana Bento da Silva1, Helena Lourenço2, Sofia Ramiro3, Louise Falzon4, Jaime Branco5, Désirée van der Heijde6, Robert Landewé7 and Alexandre Sepriano8, 1Rheumatology department, Hospital de Egas Moniz, Centro Hospitalar de Lisboa Ocidental, Lisboa, Portugal, 2Serviço de Reumatologia, Centro Hospitalar de Lisboa Ocidental, Lisboa, Portugal, 3Leiden University Medical Center, Leiden, Netherlands, 4Health Economics and Decision Science, School of Health and Related Research, University of Sheffield, Sheffield, United Kingdom, 5Hospital de Egas Moniz, Centro Hospitalar de Lisboa Ocidental, Lisboa, Portugal, 6Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands, Leiden, Netherlands, 7Amsterdam University Medical Center, Meerssen, Netherlands, 8Leiden University Medical Centre, Portela Loures, Portugal

    Background/Purpose: The Berlin algorithm for the diagnosis of axial spondyloarthritis (axSpA) was developed more than 15 years ago (2004). Since then, new studies suggest that…
  • Abstract Number: 0700 • ACR Convergence 2022

    Accurate Identification of ANCA-Associated Vasculitis Cases from Clinical Notes Using Machine Learning

    Liqing Wang1, John Laurentiev1, Claire Cook2, Eli Miloslavsky2, Hyon Choi3, Li Zhou1 and Zachary Wallace2, 1Brigham and Women's Hospital, Boston, MA, 2Massachusetts General Hospital, Boston, MA, 3MASSACHUSETTS GENERAL HOSPITAL, Lexington, MA

    Background/Purpose: ANCA-associated vasculitis (AAV) is a rare disease associated with substantial morbidity and mortality.1 To enable outcomes and comparative effectiveness studies using large, phenotypically diverse…
  • « Previous Page
  • 1
  • …
  • 30
  • 31
  • 32
  • 33
  • 34
  • …
  • 55
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology